This article is currently under investigation. We strongly recommend that this article is not cited until the investigation is completed.
Research Paper Volume 12, Issue 13 pp 12684—12702
Silencing of long non-coding RNA Sox2ot inhibits oxidative stress and inflammation of vascular smooth muscle cells in abdominal aortic aneurysm via microRNA-145-mediated Egr1 inhibition
Figure 6. Silencing of lncRNA Sox2ot binding miR-145 inhibits oxidative stress and inflammation of Ang II-treated VSMCs by downregulating Egr1. (A) Venn map for 119 intersection genes predicted to be regulated by miR-145 in the DIANA (http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=microT_CDS/index), miRWalk (http://mirwalk.umm.uni-heidelberg.de/), miRmap (https://mirmap.ezlab.org/), microRNA.org (http://www.microrna.org/microrna/home.do), and starBase (http://starbase.sysu.edu.cn/index.php); (B) a PPI network using Cytoscape 3.6.0 software for target genes of miR-145 was constructed using string database (https://string-db.org/); the color represents the correlation between miR-145 and other genes, and red represent the high correlation; (C) the complementary binding sites between miR-145 and Egr1 3'-UTR predicted by StarBase; (D) Egr1 mRNA and protein levels in the abdominal aorta of normal mice and Ang II-induced AAA mice determined by RT-qPCR and Western blot analysis; (E) interaction between miR-145 and Egr1 detected by dual luciferase reporter gene assay; (F) the interaction between miR-145 and Egr1 verified by RNA pull down assay; (G) Egr1 mRNA and protein levels in VSMCs determined by RT-qPCR and Western blot analysis; (H) cell viability of VSMCs detected by CCK-8 assay; (I) apoptosis of VSMCs detected by flow cytometry; (J) levels of COX-2, NO, IL-1β, IL-6, and TNF-α in serum of VSMCs Egr1 and/or Sox2ot/miR-145 measured by ELISA; (K) levels of MDA and SOD in serum of VSMCs measured using kits; (L) ROS level in VSMCs measured by kits; (M) protein levels of cleaved caspase-3, NOX4, iNOS, p47phox, collagen I and collagen III in VSMCs determined using Western blot analysis; * p < 0.05, vs. normal mice or VSMCs without treatment; # p < 0.05, vs. VSMCs treated with Ang II + NC-mimic, Ang II + NC-inhibitor, Ang II + NC, or Ang II + si-NC plasmids; & p < 0.05, vs. VSMCs treated with Ang II + NC-mimic or Ang II + Egr1 plasmids; measurement data were depicted as the mean ± standard deviation; comparisons between the two groups were analyzed using unpaired t-test (n = 10), and comparisons among multiple groups were analyzed using one-way ANOVA, followed by Turkey’s post hoc test; the experiment was repeated three times.